HOXA1 and hepatocellular carcinoma: As aberrant methylation of these two genes were shown to be promising blood biomarkers for HCC screening, of interest, MSqPCR assays for both HOXA1 and TSPYL5 genes were developed and tested in our archived urine DNA cohort.